If someone told you to get an eye exam, would you associate that with a virtual reality headset?

It might be where ophthalmology diagnostics will end up in the near future. Compared to the existing diagnostics tools, a VR approach is much more portable and hence accessible.

The Swiss company PeriVision is using AI and VR to enable more efficient workflows and deeper clinical insights to manage eye diseases better. I spoke with the co-founder and CEO of Perivision, Patrick Kessel. Prior to joining PeriVision, Patrick advised Medtech, biopharma, and insurance clients on business development, go-to-market strategy, digitization, and operations optimization at the Boston Consulting Group (BCG).

Parick discussed:

• How VR and AI help in eye care,

• What is the competition in the field,

• How Perivision evolved.

• Why did the company apply for the Wild Card Program and which startups this program is suitable for.

Perivison won EIT Health’s Wild Card program in 2021 and received 1.5 million euros for its further development.

This episode is supported by EIT Health Germany-Switzerland,  which is one of eight Knowledge and Innovation Communities (KICs) currently funded by the European Institute of Innovation and Technology (EIT). EiT Health Germany connects 150 renowned partners from industry, research and education from Germany, Austria and Switzerland. Find out more: eit-health.de